William L Herring

6PUBLICATIONS
19CO-AUTHORS
Economic models and forecastingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Economic development policyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2025
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review.

Olivia M Dong, Na'ngono Manga, Yue Zhong

|Jul 03, 2025
Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model.

Amir Abbas Tahami Monfared, Stephanie Barrows, Lindsey Fox

|Apr 29, 2024
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.

William L Herring, Meghan E Gallagher, Nirmish Shah

|Jan 22, 2024
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States.

Kyle Paret, Hadi Beyhaghi, William L Herring

|Dec 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

T Spelman, W L Herring, C Acosta

|Nov 01, 2022
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes.

William L Herring, Ian Gopal Gould, Villum Wittrup-Jensen

Pageof 1

Frequent Collaborators

2 joint publications

Sorrel Wolowacz

2 joint publications

Olivia M Dong

1 joint publications

T Spelman

1 joint publications

C Acosta